Benzinga's Top #PreMarket Losers
Halozyme Therapeutics (NASDAQ: HALO) fell 23.73% to $8.84 in pre-market trading after the company announced the temporary halt of Phase 2 trial enrollment.
Ocean Power Technologies (NASDAQ: OPTT) dipped 17.89% to $3.12 in the pre-market session after the company announced a proposed public offering of common stock.
CarMax (NYSE: KMX) shares dropped 5.38% to $45.00 in pre-market trading after the company reported downbeat Q4 results and lifted its share-buyback authorization by $1 billion.
Cyclacel Pharmaceuticals (NASDAQ: CYCC) dipped 4.85% to $3.53 in pre-market trading after the company priced an underwritten public offering of 2.857 million shares at $3.50 per share.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.